))
Do noradrenergic alterations in Parkinson’s disease indicate a therapeutic target? A combined PET & neuromelanin MRI study
Manage episode 410362571 series 3559181
内容由Brain提供。所有播客内容（包括剧集、图形和播客描述）均由 Brain 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Welcome to the 17th episode of The Brain Podcast - the official podcast of the journals Brain and Brain Communications.
This episode features a discussion with senior author Dr Bénédicte Ballanger of the Brain article entitled: Noradrenergic alterations in Parkinson’s disease: a combined 11C-yohimbine PET/neuromelanin MRI study
Can this multi-modal study examining the role of Noradrenaline in Parkinson's disease offer insight into important neurotrasmitter pathophysiology and provide the basis for a non-dopamine therapeutic strategy?
Check out the full article on the Brain website: https://doi.org/10.1093/brain/awad338
This episode was co-hosted by Andreas Themistocleous and Michael David, edited and produced by Michael David and Xin You Tai, co-produced by Antonia Johnston, original music by Ammar Al-Chalabi.
20集单集
分享
